Tempus AI Return on Tangible Equity 2023-2025 | TEM

Current and historical return on tangible equity values for Tempus AI (TEM) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Tempus AI Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-09-30 $-0.20B $-0.33B 70.22%
2025-06-30 $-0.20B $-0.40B 92.38%
2025-03-31 $-0.72B $-0.40B 636.64%
2024-12-31 $-0.75B $-0.03B 184.08%
2024-09-30 $-0.78B $-0.03B 102.05%
2024-06-30 $-0.77B $0.01B 101.75%
2024-03-31 $-0.28B $-1.57B 36.14%
2023-12-31 $-0.25B $-1.48B 67.16%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $12.322B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.335B 44.34
Doximity (DOCS) United States $8.258B 34.00
Hims & Hers Health (HIMS) United States $7.362B 59.89
IRhythm Technologies (IRTC) United States $5.445B 0.00
Hinge Health (HNGE) United States $3.816B 0.00
Privia Health (PRVA) United States $2.881B 180.15
Inspire Medical Systems (INSP) United States $2.816B 46.60
Heartflow (HTFL) United States $2.707B 0.00
10x Genomics (TXG) United States $2.506B 0.00
Omnicell (OMCL) United States $2.297B 46.96
Azenta (AZTA) United States $1.726B 70.83
Enovis (ENOV) United States $1.541B 8.09
Schrodinger (SDGR) United States $1.373B 0.00
Clover Health Investments (CLOV) United States $1.364B 0.00
Butterfly Network (BFLY) United States $1.079B 0.00
Phreesia (PHR) United States $1.033B 0.00
Fulgent Genetics (FLGT) United States $0.870B 0.00
Talkspace (TALK) United States $0.661B 133.00
Standard BioTools (LAB) United States $0.581B 0.00
Claritev (CTEV) United States $0.528B 0.00
Evolent Health (EVH) United States $0.463B 0.00
Zepp Health (ZEPP) Netherlands $0.387B 0.00
Carlsmed (CARL) United States $0.384B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.348B 0.00
TruBridge (TBRG) United States $0.328B 15.06
Senseonics Holdings (SENS) United States $0.291B 0.00
CapsoVision (CV) United States $0.281B 0.00
KORU Medical Systems (KRMD) United States $0.273B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.204B 0.00
Health Catalyst (HCAT) United States $0.174B 0.00
Nyxoah SA (NYXH) Belgium $0.173B 0.00
MDxHealth SA (MDXH) Belgium $0.162B 0.00
CareCloud (CCLD) United States $0.125B 6.84
Outset Medical (OM) United States $0.101B 0.00
EUDA Health Holdings (EUDA) Singapore $0.092B 0.00
HeartBeam (BEAT) United States $0.088B 0.00
Pulmonx (LUNG) United States $0.082B 0.00
American Well (AMWL) United States $0.081B 0.00
Retrieve Medical Holdings (RMHI) United States $0.068B 0.00
NetraMark Holdings (AINMF) Canada $0.067B 0.00
Precipio (PRPO) United States $0.046B 0.00
Evaxion - (EVAX) Denmark $0.043B 0.00
111 (YI) China $0.032B 0.00
Lunai Bioworks (LNAI) United States $0.022B 0.00
P3 Health Partners (PIII) United States $0.021B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
Zhongchao (ZCMD) China $0.014B 0.00
HeartSciences (HSCS) United States $0.010B 0.00
Bullfrog AI Holdings (BFRG) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
Movano (MOVE) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00